Literature DB >> 21048152

Flagellin as an adjuvant: cellular mechanisms and potential.

Steven B Mizel1, John T Bates.   

Abstract

Flagellin is a potent activator of a broad range of cell types involved in innate and adaptive immunity. An increasing number of studies have demonstrated the effectiveness of flagellin as an adjuvant, as well as its ability to promote cytokine production by a range of innate cell types, trigger a generalized recruitment of T and B lymphocytes to secondary lymphoid sites, and activate TLR5(+)CD11c(+) cells and T lymphocytes in a manner that is distinct from cognate Ag recognition. The plasticity of flagellin has allowed for the generation of a range of flagellin-Ag fusion proteins that have proven to be effective vaccines in animal models. This review summarizes the state of our current understanding of the adjuvant effect of flagellin and addresses important areas of current and future research interest.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 21048152      PMCID: PMC3756556          DOI: 10.4049/jimmunol.1002156

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  76 in total

1.  A recombinant flagellin-poxvirus fusion protein vaccine elicits complement-dependent protection against respiratory challenge with vaccinia virus in mice.

Authors:  Kristen N Delaney; James P Phipps; John B Johnson; Steven B Mizel
Journal:  Viral Immunol       Date:  2010-04       Impact factor: 2.257

2.  High-affinity interaction between gram-negative flagellin and a cell surface polypeptide results in human monocyte activation.

Authors:  P F McDermott; F Ciacci-Woolwine; J A Snipes; S B Mizel
Journal:  Infect Immun       Date:  2000-10       Impact factor: 3.441

3.  Synthetic recombinant influenza vaccine induces efficient long-term immunity and cross-strain protection.

Authors:  R Levi; R Arnon
Journal:  Vaccine       Date:  1996-01       Impact factor: 3.641

4.  Cytosolic flagellin requires Ipaf for activation of caspase-1 and interleukin 1beta in salmonella-infected macrophages.

Authors:  Luigi Franchi; Amal Amer; Mathilde Body-Malapel; Thirumala-Devi Kanneganti; Nesrin Ozören; Rajesh Jagirdar; Naohiro Inohara; Peter Vandenabeele; John Bertin; Anthony Coyle; Ethan P Grant; Gabriel Núñez
Journal:  Nat Immunol       Date:  2006-04-30       Impact factor: 25.606

5.  Vaccination with recombinant fusion proteins incorporating Toll-like receptor ligands induces rapid cellular and humoral immunity.

Authors:  James W Huleatt; Andrea R Jacobs; Jie Tang; Priyanka Desai; Elizabeth B Kopp; Yan Huang; Langzhou Song; Valerian Nakaar; T J Powell
Journal:  Vaccine       Date:  2006-08-22       Impact factor: 3.641

6.  Direct stimulation of human T cells via TLR5 and TLR7/8: flagellin and R-848 up-regulate proliferation and IFN-gamma production by memory CD4+ T cells.

Authors:  Gersende Caron; Dorothée Duluc; Isabelle Frémaux; Pascale Jeannin; Catherine David; Hugues Gascan; Yves Delneste
Journal:  J Immunol       Date:  2005-08-01       Impact factor: 5.422

7.  CD8+ T cell adjuvant effects of Salmonella FliCd flagellin in live vaccine vectors or as purified protein.

Authors:  Catarina J M Braga; Liliana M Massis; Maria E Sbrogio-Almeida; Bruna C G Alencar; Daniel Y Bargieri; Silvia B Boscardin; Maurício M Rodrigues; Luís C S Ferreira
Journal:  Vaccine       Date:  2009-11-21       Impact factor: 3.641

8.  Synthetic recombinant vaccine expressing influenza haemagglutinin epitope in Salmonella flagellin leads to partial protection in mice.

Authors:  J McEwen; R Levi; R J Horwitz; R Arnon
Journal:  Vaccine       Date:  1992       Impact factor: 3.641

9.  Superior efficacy of a recombinant flagellin:H5N1 HA globular head vaccine is determined by the placement of the globular head within flagellin.

Authors:  Langzhou Song; Yi Zhang; Nadezhda E Yun; Allison L Poussard; Jeanon N Smith; Jennifer K Smith; Viktoriya Borisevich; Jenna J Linde; Michele A Zacks; Hong Li; Uma Kavita; Lucia Reiserova; Xiangyu Liu; Kunmi Dumuren; Bhuvaneswari Balasubramanian; Bruce Weaver; Jason Parent; Scott Umlauf; Ge Liu; Jim Huleatt; Lynda Tussey; Slobodan Paessler
Journal:  Vaccine       Date:  2009-08-03       Impact factor: 3.641

10.  A fusion protein vaccine containing OprF epitope 8, OprI, and type A and B flagellins promotes enhanced clearance of nonmucoid Pseudomonas aeruginosa.

Authors:  Eric T Weimer; Haiping Lu; Nancy D Kock; Daniel J Wozniak; Steven B Mizel
Journal:  Infect Immun       Date:  2009-04-06       Impact factor: 3.441

View more
  149 in total

1.  TLR5, a novel and unidentified inflammatory mediator in rheumatoid arthritis that correlates with disease activity score and joint TNF-α levels.

Authors:  Nathan D Chamberlain; Olga M Vila; Michael V Volin; Suncica Volkov; Richard M Pope; William Swedler; Arthur M Mandelin; Shiva Shahrara
Journal:  J Immunol       Date:  2012-06-01       Impact factor: 5.422

2.  Enhanced antigen processing of flagellin fusion proteins promotes the antigen-specific CD8+ T cell response independently of TLR5 and MyD88.

Authors:  John T Bates; Aaron H Graff; James P Phipps; Jason M Grayson; Steven B Mizel
Journal:  J Immunol       Date:  2011-04-22       Impact factor: 5.422

Review 3.  Mechanisms of Cholera Toxin in the Modulation of TH17 Responses.

Authors:  Hsing-Chuan Tsai; Reen Wu
Journal:  Crit Rev Immunol       Date:  2015       Impact factor: 2.214

4.  Flagellin-rPAc vaccine inhibits biofilm formation but not proliferation of S. mutans.

Authors:  Ying Sun; Yi Yang; Dihan Zhou; Yuan Cao; Jie Yu; Bali Zhao; Maohua Zhong; Yaoming Li; Jingyi Yang; Huimin Yan
Journal:  Hum Vaccin Immunother       Date:  2016-07-08       Impact factor: 3.452

5.  Dual Immunization with SseB/Flagellin Provides Enhanced Protection against Salmonella Infection Mediated by Circulating Memory Cells.

Authors:  Seung-Joo Lee; Joseph Benoun; Brian S Sheridan; Zachary Fogassy; Oanh Pham; Quynh-Mai Pham; Lynn Puddington; Stephen J McSorley
Journal:  J Immunol       Date:  2017-07-14       Impact factor: 5.422

6.  Flagellin-expressing virus-like particles exhibit adjuvant effects on promoting IgG isotype-switched long-lasting antibody induction and protection of influenza vaccines in CD4-deficient mice.

Authors:  Eun-Ju Ko; Youri Lee; Young-Tae Lee; Yu-Jin Jung; Vu L Ngo; Min-Chul Kim; Ki-Hye Kim; Bao-Zhong Wang; Andrew T Gewirtz; Sang-Moo Kang
Journal:  Vaccine       Date:  2019-05-14       Impact factor: 3.641

7.  Salmonella flagellin acted as an effective fusion partner for expression of Plasmodium falciparum surface protein 25 in Escherichia coli.

Authors:  Feng Qian; Mengmeng Li; Yong Chen; Lin Jiang; Huji Xu
Journal:  Hum Vaccin Immunother       Date:  2016-04-08       Impact factor: 3.452

8.  Protective humoral immunity elicited by a needle-free malaria vaccine comprised of a chimeric Plasmodium falciparum circumsporozoite protein and a Toll-like receptor 5 agonist, flagellin.

Authors:  Daniel Carapau; Robert Mitchell; Adéla Nacer; Alan Shaw; Caroline Othoro; Ute Frevert; Elizabeth Nardin
Journal:  Infect Immun       Date:  2013-09-16       Impact factor: 3.441

9.  Activation of NLRC4 downregulates TLR5-mediated antibody immune responses against flagellin.

Authors:  Wei Li; Jingyi Yang; Ejuan Zhang; Maohua Zhong; Yang Xiao; Jie Yu; Dihan Zhou; Yuan Cao; Yi Yang; Yaoming Li; Huimin Yan
Journal:  Cell Mol Immunol       Date:  2015-04-27       Impact factor: 11.530

10.  rFliC prolongs allograft survival in association with the activation of recipient Tregs in a TLR5-dependent manner.

Authors:  Jing Hao; Chao Zhang; Ting Liang; Jing Song; Guihua Hou
Journal:  Cell Mol Immunol       Date:  2013-10-07       Impact factor: 11.530

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.